PhoenixBio Co (TSE:6190) Accounts Payable: 円14 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6190 PhoenixBio Co Ltd TSE:6190
56 GF Score
Price 円341.00
GF Value 円354.78
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PhoenixBio Co Accounts Payable?

PhoenixBio Co TSE:6190 -2.29% 56 Accounts Payable is 円14 Mil as of Mar. 2026. GuruFocus rates TSE:6190 with a GF Score™ of 56/100 and a GF Value™ of 円354.78 (Fairly Valued). The stock has 5 warning signs investors should review.

PhoenixBio Co's Accounts Payable for the quarter that ended in Mar. 2026 was 円14 Mil.

PhoenixBio Co's quarterly Accounts Payable declined from Mar. 2025 (円16 Mil) to Sep. 2025 (円14 Mil) and declined from Sep. 2025 (円14 Mil) to Mar. 2026 (円14 Mil).

PhoenixBio Co's annual Accounts Payable increased from Mar. 2024 (円13 Mil) to Mar. 2025 (円16 Mil) but then declined from Mar. 2025 (円16 Mil) to Mar. 2026 (円14 Mil).

PhoenixBio Co Accounts Payable Related Terms

PhoenixBio Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for PhoenixBio Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhoenixBio Co Accounts Payable Chart

PhoenixBio Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.26 40.04 12.93 16.37 13.59

PhoenixBio Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.93 23.97 16.37 13.71 13.59
TSE:6190
56GF Score
PhoenixBio Co Ltd TSE:6190
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhoenixBio Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of 円14 Mil mean?
PhoenixBio Co (TSE:6190) has a Accounts Payable of 円14 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PhoenixBio Co and its competitors.
Is PhoenixBio Co's Accounts Payable too high?
PhoenixBio Co's current Accounts Payable is 円14 Mil. Overall, PhoenixBio Co has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's Accounts Payable compare to VRTX and REGN?
PhoenixBio Co's Accounts Payable of 円14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PhoenixBio Co and its competitors. PhoenixBio Co's current Accounts Payable is 円14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Fairly Valued. The stock's GF Value™ is 円354.78, compared to a current price of 円341.00 — trading 3.9% below its estimated fair value. The current Accounts Payable is 円14 Mil. PhoenixBio Co's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current Accounts Payable is 円14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円341.00 is trading 3.9% below its estimated GF Value™ of 円354.78. GuruFocus considers PhoenixBio Co to be Fairly Valued.

Key valuation signals for TSE:6190:

  • Accounts Payable: 円14 Mil
  • GF Value™: 円354.78 vs. price of 円341.00 (3.9% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
56GF Score

Get the complete analysis for TSE:6190

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円341.00
Price
円354.78
GF Value